Merck’s Keytruda will soon lose exclusivity, just as weight-loss giants Eli Lilly and Novo Nordisk press in with their blockbuster GLP-1s.

The FDA expanded the indication of the long-acting growth hormone somapacitan (Sogroya) to include very young children with ...

In general, physicians prefer to prescribe medications that are inexpensive if they are just as good as expensive ones. There are some occasions when the newer, more expensive ones really are better.

The odor and discharge are strongly suggestive of a bacterial sinus infection. COVID infections, like all viral infections, ...

The odour and discharge are strongly suggestive of a bacterial sinus infection. COVID infections, like all viral infections, ...

Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50 percent starting next year to $675 a month, the Danish drugmaker said Feb. 24.

I am a 49-year-old woman who recently had COVID. When I was sick with it, I lost my sense of taste and smell. I no longer have COVID, but I still have a stuffy nose with no sense of taste or smell.

FAT JABS relied on by millions of slimmers could slash the risk of life-threatening complications after a heart attack, a study suggests. Semaglutide — the powerful ingredient behind Wegovy ...

A SAYS investigation found some medical practitioners are selling prescription weight-loss drugs like Ozempic without proper ...

Ozempic (R) was approved by Health Canada in 2018. Ozempic (R) is indicated for the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control.

NVO shares plunge 21% after Lilly's Zepbound and oral orforglipron beat its key GLP-1 drugs in head-to-head obesity and ...